SISU PHARMA
Sisu Pharma is dedicated to developing targeted drugs for patients with therapy-resistant Prostate Cancer. Prostate Cancer is the second most common cancer in men worldwide and there were over 1.3 million new cases of the disease globally in 2018. There are several treatments available for Prostate Cancer but none are curative and prolonged treatment inevitably results in resistance and death. Sisu Pharma’s proprietary technology specifically targets a key protein that is critical to the survival and spread of advanced Prostate Cancer, providing desperately needed treatment for patients with no remaining options.
SISU PHARMA
Social Links:
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2019-01-01
Address:
Chapel Hill, North Carolina, United States
Country:
United States
Website Url:
http://www.sisupharma.com
Total Employee:
1+
Status:
Active
Total Funding:
3.4 M USD
Similar Organizations
ImmPACT Bio
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Stromatis Pharma
Stromatis Pharma is developing a secreted frizzle-related protein 2 (sFRP2) antagonist for reverting stromal stellate cells.
Current Employees Featured
Founder
Investors List
Viva Ventures Biotech Fund
Viva Ventures Biotech Fund investment in Seed Round - Sisu Pharma
Official Site Inspections
http://www.sisupharma.com
- Host name: 47.0.153.160.host.secureserver.net
- IP address: 160.153.0.47
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
